According to The Nikkei Asia, Japanese electronics manufacturer Casio Computer will release its skin cancer detection devices in foreign markets, anticipating demand in countries with higher rates of the condition.
Casio will market its Dermocamera and dermoscope in Australia and New Zealand by March, expanding to Taiwan and the U.S. later this year. Australia had the highest rate of melanoma in 2018, followed by New Zealand, according to data compiled by the World Cancer Research Fund.
By taking this business overseas, Casio looks to lift revenue from medical devices north of 1 billion yen (US$ 9.48 million) in two to three years. The segment's sales are currently estimated between 100 million yen and 200 million yen.
The two devices work by magnifying and photographing skin lesions under different lighting conditions. A physician can identify whether the lesion is a malignant tumor based on the surface structure and coloring.
If you want to read this article in Japanese, please see the following link:
Subscribe to our English Newsletter